600 filings
Page 4 of 30
10-Q
2023 Q1
BPTH
Bio-Path Holdings Inc
Quarterly report
11 May 23
4:10pm
4
Cleaver Heath
4 May 23
BIO-PATH / Heath Cleaver ownership change
6:24pm
4
BPTH
Bio-Path Holdings Inc
4 May 23
BIO-PATH / Paul Aubert ownership change
6:00pm
4
Aline Sherwood
4 May 23
BIO-PATH / Aline Sherwood ownership change
5:49pm
4
BPTH
Bio-Path Holdings Inc
4 May 23
BIO-PATH / DOUGLAS P MORRIS ownership change
5:41pm
4
Nielsen Peter Henry
4 May 23
BIO-PATH / Peter Henry Nielsen ownership change
5:20pm
8-K
BPTH
Bio-Path Holdings Inc
31 Mar 23
Bio-path Holdings Reports Full Year 2022 Financial Results
7:10am
10-K
2022 FY
BPTH
Bio-Path Holdings Inc
Annual report
30 Mar 23
4:10pm
8-K
BPTH
Bio-Path Holdings Inc
16 Mar 23
Bio-Path Holdings Provides Clinical and Operational Update
4:30pm
S-8
BPTH
Bio-Path Holdings Inc
15 Mar 23
Registration of securities for employees
4:16pm
EFFECT
BPTH
Bio-Path Holdings Inc
9 Feb 23
Notice of effectiveness
12:15am
CORRESP
BPTH
Bio-Path Holdings Inc
6 Feb 23
Correspondence with SEC
12:00am
S-1/A
BPTH
Bio-Path Holdings Inc
IPO registration (amended)
3 Feb 23
4:14pm
UPLOAD
BPTH
Bio-Path Holdings Inc
4 Jan 23
Letter from SEC
12:00am
S-1
BPTH
Bio-Path Holdings Inc
IPO registration
28 Dec 22
5:48pm
8-K
BPTH
Bio-Path Holdings Inc
20 Dec 22
Departure of Directors or Certain Officers
4:15pm
8-K
BPTH
Bio-Path Holdings Inc
9 Dec 22
Termination of a Material Definitive Agreement
4:30pm
8-K
BPTH
Bio-Path Holdings Inc
7 Dec 22
Bio-Path Holdings Announces First Patient Dosed in Phase 1/1b Clinical Trial of BP1001-A in Solid Tumors
4:30pm
D
BPTH
Bio-Path Holdings Inc
18 Nov 22
$2.28 mm in options / securities to be acquired, sold $2.28 mm, 5 investors
5:11pm
8-K
BPTH
Bio-Path Holdings Inc
15 Nov 22
Bio-path Holdings Reports Third Quarter 2022 Financial Results
7:30am